Abstract
Two types of specific particles can be obtained from allantoic fluid preparations of influenza A and B virus. The larger particle which possesses all the attributes of the virus and which shows a sedimentation constant of about 600 S was compared with the smaller component (30 S) by complement fixation technic. The 30 S component can be differentiated from the 600 S particle by the patterns of the optimal antigen-antibody relationships and by cross-absorption of the sera with the two particles. Some of the 30 S-type antigen can be demonstrated in higher concentrations of the 600 S particles by the use of sera containing only anti-30 S; i.e., sera carefully absorbed with 600 S component. Also, upon sonic vibration of the 600 S particle, serologically active material was released which behaved in every respect like the 30 S antigen. The response of human beings to these antigens was found to vary. Antibodies to the 30 S component developed in the majority of subjects exposed to active virus either under epidemic or experimental conditions, but only rarely following vaccination with three different vaccines. In selecting sera without 30 S antibodies a fairly close correlation between the antibody titers obtained by inhibition of hemagglutination and complement fixation with the 600 S component was obtained. The presence of 30 S antibodies prevented such a correlation. The reaction with the 30 S antigen may be of value in the diagnosis and study of the epidemiology of influenza.
Full Text
The Full Text of this article is available as a PDF (1.1 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chambers L. A., Henle W., Lauffer M. A., Anderson T. F. STUDIES ON THE NATURE OF THE VIRUS OF INFLUENZA : II. THE SIZE OF THE INFECTIOUS UNIT IN INFLUENZA A. J Exp Med. 1943 Mar 1;77(3):265–276. doi: 10.1084/jem.77.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Francis T., Magill T. P., Rickard E. R., Beck M. D. Etiological and Serological Studies in Epidemic Influenza. Am J Public Health Nations Health. 1937 Nov;27(11):1141–1160. doi: 10.2105/ajph.27.11.1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Friedewald W. F., Pickels E. G. CENTRIFUGATION AND ULTRAFILTRATION STUDIES ON ALLANTOIC FLUID PREPARATIONS OF INFLUENZA VIRUS. J Exp Med. 1944 Mar 1;79(3):301–317. doi: 10.1084/jem.79.3.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henle G., Henle W. NEUROLOGICAL SIGNS IN MICE FOLLOWING INTRACEREBRAL INOCULATION OF INFLUENZA VIRUSES. Science. 1944 Nov 3;100(2601):410–411. doi: 10.1126/science.100.2601.410. [DOI] [PubMed] [Google Scholar]
- Henle W., Henle G. THE TOXICITY OF INFLUENZA VIRUSES. Science. 1945 Oct 19;102(2651):398–400. doi: 10.1126/science.102.2651.398. [DOI] [PubMed] [Google Scholar]
- Knight C. A. A SEDIMENTABLE COMPONENT OF ALLANTOIC FLUID AND ITS RELATIONSHIP TO INFLUENZA VIRUSES. J Exp Med. 1944 Aug 1;80(2):83–100. doi: 10.1084/jem.80.2.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lennette E. H., Horsfall F. L. STUDIES ON EPIDEMIC INFLUENZA VIRUS : THE NATURE AND PROPERTIES OF THE COMPLEMENT-FIXING ANTIGEN. J Exp Med. 1940 Aug 31;72(3):233–246. doi: 10.1084/jem.72.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lennette E. H., Horsfall F. L. STUDIES ON INFLUENZA VIRUS : THE COMPLEMENT-FIXING ANTIGEN OF INFLUENZA A AND SWINE INFLUENZA VIRUSES. J Exp Med. 1941 Apr 30;73(5):581–599. doi: 10.1084/jem.73.5.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stanley W. M. THE PREPARATION AND PROPERTIES OF INFLUENZA VIRUS VACCINES CONCENTRATED AND PURIFIED BY DIFFERENTIAL CENTRIFUGATION. J Exp Med. 1945 Feb 1;81(2):193–218. doi: 10.1084/jem.81.2.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stanley W. M. THE SIZE OF INFLUENZA VIRUS. J Exp Med. 1944 Mar 1;79(3):267–283. doi: 10.1084/jem.79.3.267. [DOI] [PMC free article] [PubMed] [Google Scholar]